Clinical Trial Update: Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating 11C-acetate PET imaging as a novel approach to detect pathology in pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• 11C-acetate PET imaging (11C-acetate)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis, Pulmonary | Phase 1 | Status: UNKNOWN